| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |